Terms: = Breast cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Treatment
11 results:
1. Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Li K; Cao L; Li C; Wu J; Chen B; Zhang G; Li X; Wen L; Jia M; Wei G; Lin J; Li Y; Zhang Y; Mok H; Ren C; Wang Y; Qi X; Guo L; Che Y; Liao N
Cancer Med; 2023 Mar; 12(5):5195-5208. PubMed ID: 36404592
[TBL] [Abstract] [Full Text] [Related]
2. MiR-4458-loaded gelatin nanospheres target COL11A1 for ddr2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
Biomater Sci; 2022 Aug; 10(16):4596-4611. PubMed ID: 35792605
[TBL] [Abstract] [Full Text] [Related]
3. Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive breast cancer.
Romayor I; García-Vaquero ML; Márquez J; Arteta B; Barceló R; Benedicto A
Breast J; 2022; 2022():5169405. PubMed ID: 35711892
[TBL] [Abstract] [Full Text] [Related]
4. Discoidin Domain Receptor 2: A New Target in cancer.
Xu X; Yu T; Wang Z
Oncol Res Treat; 2022; 45(4):205-215. PubMed ID: 35073544
[TBL] [Abstract] [Full Text] [Related]
5. Tyrosine kinase-independent actions of ddr2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis.
Barcus CE; Hwang PY; Morikis V; Brenot A; Pence P; Clarke M; Longmore GD
J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34477203
[TBL] [Abstract] [Full Text] [Related]
6. ddr2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
Lin CC; Yang WH; Lin YT; Tang X; Chen PH; Ding CC; Qu DC; Alvarez JV; Chi JT
Oncogene; 2021 Mar; 40(11):2018-2034. PubMed ID: 33603168
[TBL] [Abstract] [Full Text] [Related]
7. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.
Vella V; Malaguarnera R; Nicolosi ML; Morrione A; Belfiore A
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118522. PubMed ID: 31394114
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of ddr2 extracellular domain.
Grither WR; Longmore GD
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7786-E7794. PubMed ID: 30061414
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.
Santoni M; Guerra F; Conti A; Lucarelli A; Rinaldi S; Belvederesi L; Capucci A; Berardi R
Cancer Treat Rev; 2017 Sep; 59():123-131. PubMed ID: 28818671
[TBL] [Abstract] [Full Text] [Related]
10. Discoidin domain receptor 2 (ddr2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract] [Full Text] [Related]
11. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.
Zhang K; Corsa CA; Ponik SM; Prior JL; Piwnica-Worms D; Eliceiri KW; Keely PJ; Longmore GD
Nat Cell Biol; 2013 Jun; 15(6):677-87. PubMed ID: 23644467
[TBL] [Abstract] [Full Text] [Related]